Health and Healthcare

Eli Lilly : LLY

All Eli Lilly Articles

668 Articles

Chris Lange | Jun 26, 2019 at 8:30 AM EDT

Short Sellers Seek Direction on Big Pharma

The June 14 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Jun 12, 2019 at 8:30 AM EDT

Big Pharma Sees a Rising Tide in Short Interest

The May 31 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | May 28, 2019 at 8:50 AM EDT

Big Pharma Short Sellers Hike Their Bets

The May 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | May 22, 2019 at 11:40 AM EDT

How Eli Lilly Is Making Insulin More Affordable

Eli Lilly has announced that its Insulin Lispro Injection is now available for order in pharmacies for people who use…

Chris Lange | May 10, 2019 at 10:15 AM EDT

Big Pharma Scares Off Short Sellers

The April 30 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | May 9, 2019 at 2:10 PM EDT

2 Pharma Giants Shine as Wall Street Brings Strong IPOs for Cortexyme and NextCure

It's an impressive day when two IPOs are well received when drug-selling revenues are unlikely for quite some time, and…

Chris Lange | Apr 26, 2019 at 8:45 AM EDT

Big Pharma Scares Off Short Sellers

The April 15 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Apr 24, 2019 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Apple, Best Buy, Eli Lilly, Hilton, Hyatt, Kraft Heinz, Procter & Gamble, Snap and More

The top analyst upgrades, downgrades and initiations seen on Wednesday included Apple, Best Buy, Eli Lilly, Hilton, Hyatt, Kraft Heinz,…

Jon C. Ogg | Apr 11, 2019 at 8:45 AM EDT

Top Analyst Upgrades and Downgrades: Apple, Chipotle, CEMEX, CVS, Eli Lilly, Hewlett Packard Enterprise, IBM, Incyte, MercadoLibre, US Steel and More

The top analyst upgrades, downgrades and initiations seen on Thursday included Apple, Chipotle Mexican Grill, CEMEX, CVS, Eli Lilly, Hewlett…

Chris Lange | Apr 10, 2019 at 9:40 AM EDT

Unbelievable Swings in Big Pharma Short Interest

The March 29 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Mar 27, 2019 at 8:50 AM EDT

Major Pharma Sees a Few Wild Swings in Short Interest

The March 15 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Mar 23, 2019 at 7:01 AM EDT

Sell-Off or Not, 7 Blue Chips and Industry Leaders Analysts Want You to Buy Now

The week of March 22, 2019, ended on a very sour note with the markets selling off sharply. That said,…

Jon C. Ogg | Mar 20, 2019 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Allergan, Costco, Cree, Dollar Tree, Eli Lilly, FedEx, Mylan, NextEra, Peabody, Teva, Yum Brands and More

The top analyst upgrades, downgrades and initiations seen on Wednesday included Allergan, Costco, Cree, Dollar Tree, Eli Lilly, FedEx, Mylan,…

Jon C. Ogg | Mar 12, 2019 at 8:45 AM EDT

Top Analyst Upgrades and Downgrades: AEP, Apple, Boeing, Coca-Cola, Eli Lilly, RingCentral, Tellurian, Tesla, Vonage and More

The top analyst upgrades, downgrades and initiations seen on Tuesday included American Electric Power, Apple, Boeing, Coca-Cola, Eli Lilly, RingCentral,…

Chris Lange | Mar 12, 2019 at 8:35 AM EDT

Big Pharma Short Interest Backs Off, With One Huge Exception

The February 28 short interest data have been compared with the previous figures, and short interest in most of these…

1 … 18 19 20 21 22 … 45

Eli Lilly : LLY

All Eli Lilly Articles

Short Sellers Seek Direction on Big Pharma

Big Pharma Sees a Rising Tide in Short Interest

Big Pharma Short Sellers Hike Their Bets

How Eli Lilly Is Making Insulin More Affordable

Big Pharma Scares Off Short Sellers

2 Pharma Giants Shine as Wall Street Brings Strong IPOs for Cortexyme and NextCure

Big Pharma Scares Off Short Sellers

Top Analyst Upgrades and Downgrades: Apple, Best Buy, Eli Lilly, Hilton, Hyatt, Kraft Heinz, Procter & Gamble, Snap and More

Top Analyst Upgrades and Downgrades: Apple, Chipotle, CEMEX, CVS, Eli Lilly, Hewlett Packard Enterprise, IBM, Incyte, MercadoLibre, US Steel and More

Unbelievable Swings in Big Pharma Short Interest

Major Pharma Sees a Few Wild Swings in Short Interest

Sell-Off or Not, 7 Blue Chips and Industry Leaders Analysts Want You to Buy Now

Top Analyst Upgrades and Downgrades: Allergan, Costco, Cree, Dollar Tree, Eli Lilly, FedEx, Mylan, NextEra, Peabody, Teva, Yum Brands and More

Top Analyst Upgrades and Downgrades: AEP, Apple, Boeing, Coca-Cola, Eli Lilly, RingCentral, Tellurian, Tesla, Vonage and More

Big Pharma Short Interest Backs Off, With One Huge Exception

Ryanair CFO: Rival Airlines Could Fail This Winter; Industry Shakeout Could Lead to Pricing Power

The Divorce Settlement Mistake Costing Retirees Thousands

3 Reasons I’m Buying Amazon Over and Over Until Late 2026

The Roth Conversion Window That Closes Faster Than Most 401(k) Savers Expect

If You Just Inherited an IRA, Read This

If I Could Only Own 1 ETF for the Rest of 2026, It Would Be This One

Ryanair CFO: Rival Airlines Could Fail This Winter; Industry Shakeout Could Lead to Pricing Power

Eli Lilly : LLY

All Eli Lilly Articles

Short Sellers Seek Direction on Big Pharma

Big Pharma Sees a Rising Tide in Short Interest

Big Pharma Short Sellers Hike Their Bets

How Eli Lilly Is Making Insulin More Affordable

Big Pharma Scares Off Short Sellers

2 Pharma Giants Shine as Wall Street Brings Strong IPOs for Cortexyme and NextCure

Big Pharma Scares Off Short Sellers

Top Analyst Upgrades and Downgrades: Apple, Best Buy, Eli Lilly, Hilton, Hyatt, Kraft Heinz, Procter & Gamble, Snap and More

Top Analyst Upgrades and Downgrades: Apple, Chipotle, CEMEX, CVS, Eli Lilly, Hewlett Packard Enterprise, IBM, Incyte, MercadoLibre, US Steel and More

Unbelievable Swings in Big Pharma Short Interest

Major Pharma Sees a Few Wild Swings in Short Interest

Sell-Off or Not, 7 Blue Chips and Industry Leaders Analysts Want You to Buy Now

Top Analyst Upgrades and Downgrades: Allergan, Costco, Cree, Dollar Tree, Eli Lilly, FedEx, Mylan, NextEra, Peabody, Teva, Yum Brands and More

Top Analyst Upgrades and Downgrades: AEP, Apple, Boeing, Coca-Cola, Eli Lilly, RingCentral, Tellurian, Tesla, Vonage and More

Big Pharma Short Interest Backs Off, With One Huge Exception

Ryanair CFO: Rival Airlines Could Fail This Winter; Industry Shakeout Could Lead to Pricing Power

The Divorce Settlement Mistake Costing Retirees Thousands

3 Reasons I’m Buying Amazon Over and Over Until Late 2026

Featured Reads

The Roth Conversion Window That Closes Faster Than Most 401(k) Savers Expect

If You Just Inherited an IRA, Read This